What Peptide Therapy Actually Does to Aging — And What It Doesn't

You're 47, your recovery after workouts has stretched from one day to three, your sleep is lighter than it used to be, and a recent panel showed IGF-1 sitting at 98 ng/mL — technically within the broad "normal" range but closer to what you'd expect from someone fifteen years older. Your doctor says everything looks fine. The anti-aging clinic down the street is promising you a different story. Somewhere between those two conversations is where most people trying to evaluate peptide therapy end up.

What the Research Actually Shows on Growth Hormone Secretagogues

The category most people mean when they talk about "anti-aging peptides" is growth hormone secretagogues — compounds like sermorelin, CJC-1295, and ipamorelin. These aren't growth hormone itself; they stimulate the pituitary to release more of its own. That distinction matters clinically.

Sermorelin has the longest track record. A study by Vittone et al. (1997) using 30 mcg/kg administered subcutaneously three times weekly in adults over 60 documented measurable increases in IGF-1 and improvements in sleep architecture — specifically slow-wave sleep, which is where most growth hormone secretion naturally occurs. The effect on body composition was modest: roughly 2–3% reduction in fat mass over 24 weeks without dietary intervention. That's not a dramatic number, but it's real and reproducible.

CJC-1295 with DAC (drug affinity complex) carries an approximately six-to-eight-day half-life compared to sermorelin's roughly 11 minutes, which is why protocols dose it weekly rather than nightly. Most clinical protocols run it at 1–2 mg per week subcutaneously. Phase I/II trials have documented measurable GH pulse amplitude effects, but long-term outcome data in adults without diagnosed GH deficiency remains limited.

The IGF-1 Numbers That Actually Matter

Before spending anything on a peptide protocol, getting an IGF-1 and GH stimulation panel is essential context. The Endocrine Society's clinical practice guideline on adult GH deficiency uses an IGF-1 standard deviation score (SDS) below −2 as a diagnostic threshold, but people with symptoms and poor outcomes frequently cluster between −1 and −2. Reference labs typically place the adult range for a 45-year-old male at roughly 90–250 ng/mL and a 35-year-old female at 100–270 ng/mL. Knowing exactly where you sit determines which protocol, if any, makes sense.

Programs that skip this step and move directly to peptide prescriptions based on symptom questionnaires alone are operating in a grey zone. Some online peptide programs now include baseline labs in their onboarding — verify that a program requires bloodwork before prescribing, not after.

BPC-157 and the Tissue Repair Claims

BPC-157 occupies a different lane from the GH secretagogues. It's a 15-amino-acid peptide derived from a protein found in gastric juice, and most of the mechanistic research has been in rodent models of tendon, ligament, and gut repair — where the results are genuinely striking. The translation gap is the core issue: animal data showing accelerated Achilles tendon healing in rats at 10 mcg/kg has not been validated in large-scale human RCTs.

The safety profile in human anecdotal use at doses of 250–500 mcg daily (subcutaneous or oral) appears benign, and mechanistic plausibility through nitric oxide pathways and growth factor upregulation is credible enough that serious researchers haven't dismissed it. If your goal is injury recovery and connective tissue support rather than systemic GH axis optimisation, BPC-157 is the more targeted tool. The absence of FDA approval as a drug means it currently exists in the US as a compounded peptide — subject to how FDA and compounding pharmacy rules interact in any given month of 2026.

What Clinics Charge and What That Buys You

A supervised sermorelin-only protocol through a telehealth platform currently runs $150–$250/month including medication. A combined CJC-1295 / ipamorelin stack with quarterly lab monitoring typically comes in at $300–$500/month depending on the provider. Multi-peptide panels — stacking a GH secretagogue with BPC-157 and sometimes a NAD+ precursor — reach $600–$900/month at concierge clinics.

System Labs and Yucca Health represent the telehealth end of that range: structured protocols, required labs, licensed prescribers, and pricing that keeps quarterly monitoring baked in rather than charged separately. That structure matters more than the brand — the compounded peptide dispensed by any legitimate licensed pharmacy at the same molecule and dose should behave identically.

The Claims That Outrun the Data

Three outcomes commonly marketed as peptide therapy results that deserve harder scrutiny:

"Reverses cellular aging" — Telomere length studies with Epitalon (epithalon) show some data in animal models and limited human work, but no peer-reviewed RCT has demonstrated meaningful telomere lengthening in humans from any currently available peptide at commercial doses.

"Dramatic fat loss" — Growth hormone secretagogues produce modest shifts in body composition, not the fat loss associated with GLP-1 therapy. A 2–4% reduction in fat mass over six months is a realistic expectation from a GH secretagogue protocol; 15–20% is not.

"No side effects" — Water retention, transient insulin resistance, and increased cortisol response are documented with supra-physiologic GH stimulation. They are dose-dependent and manageable, but they are real.

The Practical Takeaway

If your IGF-1 is genuinely below age-adjusted normal, a supervised secretagogue protocol with quarterly monitoring has real supporting evidence. If your labs are mid-range and you're pursuing optimisation rather than treating a deficiency, the effects are likely smaller and the cost-benefit calculation less favorable. BPC-157 for specific tissue repair sits on a different evidence tier — credible mechanism, limited human trials — and is best used as an adjunct rather than a primary anti-aging intervention.

Get the actual numbers before spending $400/month: IGF-1, GH stimulation if warranted, and a full metabolic panel. Use the peptide clinics directory to find providers who require that bloodwork upfront. The ones who don't are a signal worth heeding.

---

Peptide Clinic Finder is a comparison platform. The author may receive compensation if you sign up through links on our partner pages.

---